These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

780 related items for PubMed ID: 16771219

  • 41. Interruption of indigenous measles transmission in Bolivia since October 2000.
    Quiroga R, Barrezueta O, Venczel L, Halkyer P, Gil F, Machicao E, Landaverde M, Quiñonez A, Izurieta H.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S121-6. PubMed ID: 12721902
    [Abstract] [Full Text] [Related]

  • 42. [Measles outbreaks in the Bern canton].
    Maurer AM, Mühlemann K.
    Schweiz Med Wochenschr; 1998 Feb 28; 128(9):317-22. PubMed ID: 9544458
    [Abstract] [Full Text] [Related]

  • 43. Progress toward measles control - African region, 2001-2008.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Sep 25; 58(37):1036-41. PubMed ID: 19779399
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G.
    Przegl Epidemiol; 2003 Sep 25; 57(2):281-8. PubMed ID: 12910596
    [Abstract] [Full Text] [Related]

  • 46. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
    Jaber SM.
    Saudi Med J; 2006 Jan 25; 27(1):63-9. PubMed ID: 16432596
    [Abstract] [Full Text] [Related]

  • 47. Outbreak of measles and rubella in refugee transit camps.
    Kouadio IK, Koffi AK, Attoh-Toure H, Kamigaki T, Oshitani H.
    Epidemiol Infect; 2009 Nov 25; 137(11):1593-601. PubMed ID: 19379539
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA, Barakat SS, Abd El Fattah MM, Said ZN, El Metwally HA.
    East Mediterr Health J; 2009 Nov 25; 15(1):85-93. PubMed ID: 19469430
    [Abstract] [Full Text] [Related]

  • 50. Population immunity to measles in the United States, 1999.
    Hutchins SS, Bellini WJ, Coronado V, Jiles R, Wooten K, Deladisma A.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [Abstract] [Full Text] [Related]

  • 51. Analysis of the cause of increased measles incidence in Xinjiang, China in 2004.
    Yu X, Wang S, Guan J, Mahemuti, Purhati, Gou A, Liu Q, Jin X, Ghildyal R.
    Pediatr Infect Dis J; 2007 Jun 01; 26(6):513-8. PubMed ID: 17529869
    [Abstract] [Full Text] [Related]

  • 52. Efficacy of two dose measles vaccination in a community setting.
    Phadke MA, Bhargava I, Dhaigude P, Bagade A, Biniwale MA, Kurlekar SU.
    Indian Pediatr; 1998 Aug 01; 35(8):723-5. PubMed ID: 10216565
    [Abstract] [Full Text] [Related]

  • 53. [The impact of immunization against measles on epidemiology of measles in Poland].
    Janaszek W.
    Przegl Epidemiol; 1998 Aug 01; 52(4):413-25. PubMed ID: 10321085
    [Abstract] [Full Text] [Related]

  • 54. American Academy of Pediatrics. Committee on Infectious Diseases. Age for routine administration of the second dose of measles-mumps-rubella vaccine.
    American Academy of Pediatrics. Committee on Infectious Diseases.
    Pediatrics; 1998 Jan 01; 101(1 Pt 1):129-33. PubMed ID: 11345975
    [Abstract] [Full Text] [Related]

  • 55. Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign.
    Kelly HA, Gidding HF, Karapanagiotidis T, Leydon JA, Riddell MA.
    BMC Public Health; 2007 Jun 08; 7():99. PubMed ID: 17555601
    [Abstract] [Full Text] [Related]

  • 56. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience.
    Morice A, Carvajal X, León M, Machado V, Badilla X, Reef S, Lievano F, Depetris A, Castillo-Solórzano C.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S158-63. PubMed ID: 12721908
    [Abstract] [Full Text] [Related]

  • 57. EPI sentinel surveillance for Kwara, 1982-1987.
    Babaniyi O.
    West Afr J Med; 1993 May 15; 12(4):218-22. PubMed ID: 8199064
    [Abstract] [Full Text] [Related]

  • 58. Progress toward measles eradication in the region of the Americas.
    De Quadros CA, Izurieta H, Carrasco P, Brana M, Tambini G.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S102-10. PubMed ID: 12721900
    [Abstract] [Full Text] [Related]

  • 59. Approach to verify the status of measles, rubella, and congenital rubella syndrome elimination in Costa Rica.
    Morice A, Avila-Aguero ML, Salas-Peraza D, Soriano A, Castillo-Solórzano C.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S690-7. PubMed ID: 21954268
    [Abstract] [Full Text] [Related]

  • 60. Progress toward interruption of endemic measles transmission in Tunisia.
    Garbouj M, Slim A, Ghorbal MB, Khamassi S, Gaafar T, Moshni E, Lievano F.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S172-6. PubMed ID: 12721910
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.